Diagnosis and management of Pneumocystis jirovecii infection

References

• Fannin S, Gottlieb MS, Weisman JD, et al. A cluster of Kaposi’s Sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los angeles and range counties, California. MMWR Weekly. 1982;31(32):305–307.
   PubMedGoogle Scholar
• Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia. New Eng J Med. 1981;305(24):1431–1438.
   PubMed Web of Science ®Google Scholar
• Phair J, Munoz A, Detels R, et al. The risk of pneumocystis carinii pneumonia, among men infected with human immunodeficiency virus type 1. Multi-center AIDS Cohort Study Group. N Engl J Med. 1990;322(3):161–165.
   PubMed Web of Science ®Google Scholar
• Buchacz K, Baker RK, Palella FJ, et al. AIDS-Defining opportunistic illnesses in US patients, 1994-2007: a cohort study. Aids. 2010;24(10):1549–1559.
   PubMed Web of Science ®Google Scholar
• Maini R, Henderson KL, Sheridan EA, et al. Increasing Pneumocystis pneumonia, England, UK, 2000-2010. Emerg Infect Dis. 2013;19(3):386–392.
   PubMed Web of Science ®Google Scholar
• Avino LJ Naylor SM and Roecker AM. Pneumocystis jirovecii pneumonia in the non-HIV infected population. Ann Pharmacother. 2016;50(8):673–679.
   PubMed Web of Science ®Google Scholar
• Atwal SS, Puranik S, Mehra S, et al. Pneumocystis pneumonia - a novel complication in a non-HIV dengue patient. J Clin Diagn Res. 2014;8(9):RL01–2.
   PubMedGoogle Scholar
• Vargas SL, Hughes WT, Santolaya ME, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal healthy infants. Clin Infect Dis. 2001;32(6):855–861.
   PubMed Web of Science ®Google Scholar
• Respaldiza N, Medrano FJ, Medrano AC, et al. High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect. 2004;10(11):1029–1031.
   PubMed Web of Science ®Google Scholar
• Yianniakis EP, Boswell TC. Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control. J Hosp Infect. 2016;93(1):1–8.
   PubMed Web of Science ®Google Scholar
• Beard CB, Carter JL, Keely SP, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6(3):265–272.
   PubMed Web of Science ®Google Scholar
• Panel on opportunistic infections in HIV-infected adults and adolescents. guidelines for the prevention and treatment of opportunistic infections in hiv-infected adults and adolescents: recommendations from the centers for disease control and prevention, the national institutes of health, and the hiv medicine association of the infectious diseases society of America. Accessed 10 10 2016. B-1 to B-16.
   Google Scholar
• Maertens J, Cesaro S, Maschmeyer G, et al. 5th European Conference on Infections in Leukaemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organisation for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN). ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2397–2404.
   PubMed Web of Science ®Google Scholar
• Martin SI, Fishman JA, AST Infectious Diseases Community of Practice. Pneumocystis pneumonia in Solid organ transplantation. Am J Translant. 2013;13:272–279.
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Cesaro S, Maschmeyer G, et al. Fifth European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2379–2385.
   PubMed Web of Science ®Google Scholar
• Alanio A, Hauser PM, Lagrou K, et al. 5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2386–2396.
   PubMed Web of Science ®Google Scholar
• Panel on Opportunistic Infections in HIV-exposed and HIV-Infected children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-Infected children. Department of Health and Human Services. Accessed 11 10 2016. Page numbers W-1 to W-16.
   Google Scholar
• Maschmeyer G, Helweg-Larsen J, Pagano L, et al. 6th European Conference on Infections in Leukemia (ECIL-6), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN). ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016;71(9):2405–2413.
   PubMed Web of Science ®Google Scholar
• Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010. J Infect Dis. 2016;214:862–872.
   PubMed Web of Science ®Google Scholar
• Pegorie M, Denning DW, Welfare W. Estimating the burden of invasive and serious fungal disease in the United Kingdom. J Infect. 2017;74:60–71.
   PubMed Web of Science ®Google Scholar
• Williams KM, Ahn KW, Chen M, et al. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Bone Marrow Transplant. 2016;51:573–580.
   PubMed Web of Science ®Google Scholar
• Mu X-D, Jia P, Gao L, et al. Relationship between radiological stages and prognoses of Pneumocystis pneumonia in non-AIDS immunocompromised patients. Chin Med J. 2016;129(17):2020–2025.
   PubMed Web of Science ®Google Scholar
• Diederich S. Chest CT for suspected pulmonary complications of oncologic therapies: how I review and report. Cancer Imaging. 2016;16(7). DOI:10.1186/s40644-016-0066-4.
   PubMed Web of Science ®Google Scholar
• Nambu A, Ozawa K, Kobayashi N, et al. Imaging of community-acquired pneumonia: roles of imaging examinations, imaging diagnosis of specific pathogens and discrimination from non-infectious diseases. World J Radiol. 2014;6(10):779–793.
   PubMedGoogle Scholar
• Chou C-W, Chao H-S, Lin F-C, et al. Clinical usefulness of HRCT in assessing the severity of Pneumocystis jirovecii pneumonia. Medicine. 2015;94(16):e768.
   PubMed Web of Science ®Google Scholar
• Langevin B, Saleh M. Radiological presentation of Pneumocystis jirovecii pneumonia mimicking bacterial pneumonia. BMJ Case Rep. 2016. DOI:10.1136/bcr-2016-215207
   PubMedGoogle Scholar
• Kim H, Park SY, Lee HY, et al. Ultra low dose chest CT in patients with neutropenic fever and haematological malignancy: image quality and its diagnostic performance. Cancer Res Treat. 2014;46(4):393–402.
   PubMed Web of Science ®Google Scholar
• Kono M, Yamashita H, Kubota K. FDG-PET imaging in Pneumocystis pneumonia. Clin Nucl Med. 2015;40:679–681.
   PubMed Web of Science ®Google Scholar
• Shafiek H, Fiorentino F, Cosio B, et al. Usefulness of bronchoscopic probe-based confocal laser endomicroscopy in the diagnosis of Pneumocystis jirovecii pneumonia. Respiration. 2016;92:40–47.
   PubMed Web of Science ®Google Scholar
• Wang HW, Lin CC, Kuo CF, et al. Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation: experience in a tertiary care hospital of northern Taiwan. J Microbiol Immunol Infect. 2011;44(4):274–281.
   PubMedGoogle Scholar
• Vogel MN, Weissgerber P, Goeppert B, et al. Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia. Swiss Med Wkly. 2011;141:w13184.
   PubMed Web of Science ®Google Scholar
• Zeglen S, Wojarski J, Wozniak-Grygiel E, et al. Procalcitonin serum concentration during Pneumocystis jiroveci colonisation or Pseudomonas aeruginosa infection/colonisation in lung transplant recipients. Transplant Proc. 2009;41:3225–3227.
   PubMed Web of Science ®Google Scholar
• Nyamande K, Lalloo UG. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP. Int J Tuberc Lund Dis. 2006;10:510–515.
   PubMed Web of Science ®Google Scholar
• Salerno D, Mushatt D, Myers L, et al. Serum and BAL beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients. Resp Med. 2014;108:1688–1695.
   PubMed Web of Science ®Google Scholar
• Fei MW, Kim EJ, Sant CA, et al. Prediciting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax. 2009;64:1070–1076.
   PubMed Web of Science ®Google Scholar
• Schildgen V, Mai S, Khalfaoui S, et al. Pneumocystis jiroveci can be productively cultured in differentiated CuFi-8 airway cells. Mbio. 2014;5(3):e01186–14.
   PubMed Web of Science ®Google Scholar
• Merali S, Frevert U, Williams JH, et al. Continuous axenic cultivation of Pneumocystis carinii. Proc Natl Acad Sci USA. 1999;96:2402–2407.
   PubMed Web of Science ®Google Scholar
• Sobolweska A, Dzbenski TH. In vitro cultivation of Pneumocystis isolated from infected rat lungs. Wiad Parazytol. 2009;55(4):451–457.
   PubMedGoogle Scholar
• Huang MJ, An YJ, Li SZ, et al. Continuous axenic cultivation of Pneumocystis carinii isolated from the bronchoalveolar lavage fluid of infected rat. Zhongguo Ji Sheng Chong Xue Ji Sheng Chong Bing Za Zhi. 2007;25(2):129–132.
   PubMedGoogle Scholar
• Martinez A, Halliez MCM, Aliouat EM, et al. Growth and airborne transmission of cell sorted life cycle stages of Pneumocystis carinii. PLoS One. 2013;8(11):e79958.
   PubMed Web of Science ®Google Scholar
• Ma L, Chen Z, Huang Da W, et al. Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts. Nat Commun. 2016 Feb 22;7:10740.
   PubMed Web of Science ®Google Scholar
• Procop GW, Haddad S, Quinn J, et al. Detection of Pneumocystis jirovecii in respiratory specimens by four staining methods. J Clin Microbiol. 2004;42(7):3333–3335.
   PubMed Web of Science ®Google Scholar
• Desoubeaux G, Franck-Martel C, Caille A, et al.Use of calcofluor-blue brightener for the diagnosis of Pneumocystis jirovecii pneumonia in bronchial-alveolar lavage fluids: a single-centre prospective study. Med Mycol. 2016. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Flori P, Bellete B, Durand F, et al. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jirovecii pneumonia from bronchoalveolar lavage specimens. J Med Microbiol. 2004;53:603–607.
   PubMed Web of Science ®Google Scholar
• Cregan P, Yamamoto A, Lum A, et al. Comparison of four methods for rapid detection of Pneumocystis carnii in respiratory specimens. J Clin Microbiol. 1990;28:2432–2436.
   PubMed Web of Science ®Google Scholar
• Cruciani M, Marcati P, Malena M, et al. Meta-analysis of diagnostic procedures for Pneumocystis carnii pneumonia in HIV-1-infected patients. Eur Resp J. 2002;20:982–989.
   PubMed Web of Science ®Google Scholar
• Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of b-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect. 2013;19(1):39–49.
   PubMed Web of Science ®Google Scholar
• Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-β-D-Glucan for Pneumocystis jiroveci Pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50(1):7–15.
   PubMed Web of Science ®Google Scholar
• Li WJ, Guo YL, Liu TJ, et al. Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: abivariate meta-analysis and systematic review. Thorac Dis. 2015;7(12):2214–2225.
   PubMed Web of Science ®Google Scholar
• Kamada T Furuta K and Tomioka H. Pneumocystis pneumonia associated with human immunodeficiency virus infection without elevated (1-3)-β-D-Glucan: a case report. Respir Med Case Rep. 2016;18:73–75.
   PubMed Web of Science ®Google Scholar
• White PL, Wingard JR, Bretagne S, et al. Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis. 2015;61(8):1293–1303.
   PubMed Web of Science ®Google Scholar
• Summah H, Zhu Y-G, Falagas ME, et al. Use of real-time polymerase chain reaction for the diagnosis of Pneumocystis pneumonia in immuncompromised patients: a meta-analysis. Chin Med J. 2013;126:1965–1973.
   PubMed Web of Science ®Google Scholar
• Fan L-C, Lu H-W, Cheng K-B, et al. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One. 2013;8:e73099.
   PubMed Web of Science ®Google Scholar
• Lu Y, Ling G, Qiang C, et al. PCR Diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis. J Clin Microbiol. 2011;49:4361–4363.
   PubMed Web of Science ®Google Scholar
• Pisculli ML, Sax PE. Use of a serum β-Glucan assay for diagnosis of HIV-related Pneumocystis jirovecii pneumonia in patients with negative microscopic examination results. Clin Infect Dis. 2008;46:1928–1930.
   PubMed Web of Science ®Google Scholar
• Rose SR, Vallabhajosyula S, Velez MG, et al. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections. J Infect. 2014;69(3):278–283.
   PubMed Web of Science ®Google Scholar
• Damiani C, Le Gal S, Da Costa C, et al. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1-3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonisation. Jclin Microbiol. 2013;51:3380–3388.
   PubMed Web of Science ®Google Scholar
• Tasaka S, Kobayashi S, Yagi K, et al. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonisation. J Infect Chemother. 2014;20(11):678–681.
   PubMed Web of Science ®Google Scholar
• Damiani C, Le Gal S, Goin N, et al. Usefulness of (1,3) β-D-Glucan detection in bronchoalveolar lavage samples in Pneumocystis pneumonia and Pneumocystis pulmonary colonisation. J Mycol Med. 2015;25(1):36–43.
   PubMed Web of Science ®Google Scholar
• Le Gal S, Robert-Gangneux F, Pepino Y, et al.A mis-leading false negative result of Pneumocystis real-time PCR assay due to a rare punctual mutation: a French multicenter study. Med Mycol. 2017;55:180-184.
   Google Scholar
• Guigue N, Alanio A, Menotti J, et al. Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immuncompromised adult patients with febrile pneumonia. Med Mycol. 2015;53:241–247.
   PubMed Web of Science ®Google Scholar
• Fauchier T, Hasseine L, Gari_Toussaint M, et al. Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonisation and pneumonia in immunocompromised HIV-positive and HIV-negative patients. J Clin Microbiol. 2016;54:1487–1495.
   PubMed Web of Science ®Google Scholar
• Botterel F, Cabaret O, Foulet F, et al. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J Clin Microbiol. 2012;50:227–231.
   PubMed Web of Science ®Google Scholar
• Alanio A, Desoubeaux G, Sarfati C, et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonisation in immunocompromised patients. Clin Microbiol Infect. 2011;17:1531–1537.
   PubMed Web of Science ®Google Scholar
• Sasso M, Chastang-Dumas E, Bastide S, et al. Performances of four real-time PCR assays for the diagnosis of Pneumocystis jirovecii Pneumonia. J Clin Microbiol. 2016;54:625–630.
   PubMed Web of Science ®Google Scholar
• Montesinos I, Delforge M-L, Ajjaham F, et al. Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase(DHPS) mutations. Diag Microbiol Infect Dis. 2017;87:32-36..
   Web of Science ®Google Scholar
• Lee CH, Helweg-Larsen J, Tang X, et al. Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol. 1998;36(3):734–741.
   PubMed Web of Science ®Google Scholar
• Lu JJ, Lee CH. Pneumocystis pneumonia. J Formos Med Assoc. 2008;107(11):830–842.
   PubMed Web of Science ®Google Scholar
• Alanio A, Gits-Muselli M, Mercier-Delarue S, et al. Diversity of Pneumocystis jirovecii during infection revealed by ultra-deep pyrosequencing. Front Microbiol. 2016;24(7):733.
   Google Scholar
• Depypere M, Saegeman V, Lagrou K. Typing of Pneumocystis jirovecii by multiclocus sequencing: evidence of outbreak? Eur J Clin Microbiol Infect Dis. 2016;35:911–916.
   PubMed Web of Science ®Google Scholar
• Esteves F, De Sousa B, Calderon EJ, et al. Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia. Clin Microbiol Infect. 2016;22:e9–566.e19.
   PubMed Web of Science ®Google Scholar
• Costa J-M, Botterel F, Cabaret O, et al. Association between circulating DNA, serum (1-3)-β-D-Glucan and pulmonary fungal burden in Pneumocystis pneumonia. Clin Infect Dis. 2015;55:e5–e8.
   Web of Science ®Google Scholar
• Mühlethaler K, Bögli-Stuber K, Wasmer S, et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J. 2012;39(4):971–978.
   PubMed Web of Science ®Google Scholar
• Esteves F, Lee CH, De Sousa B, et al. (1-3)- β-D-Glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2014;33:1173–1180.
   PubMed Web of Science ®Google Scholar
• Esteves F, Cale SS, Badura R, et al. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers. Clin Microbiol Infect. 2015;21: 379e1-10.
   Web of Science ®Google Scholar
• Cushion MT, Collins MS. Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrob Agents Chemother. 2011;55(10):4513–4518.
   PubMed Web of Science ®Google Scholar
• Baddley JW, Winthrop KL, Chen L, et al. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study. Ann Rheum Dis. 2014;73:1942–1948.
   PubMed Web of Science ®Google Scholar
• Alvarez B, Arcos J, Fernandez-Guerrero ML. Pulmonary infectious diseases in patients with primary immunodeficiency and those treated with biologic immunomodulating agents. Curr Opin Pulm Med. 2011;17:172–179.
   PubMed Web of Science ®Google Scholar
• Green H, Paul M, Vidal L, et al. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82:1052–1059.
   PubMed Web of Science ®Google Scholar
• Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK, et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med. 1992;327(26):1836–1841.
   PubMed Web of Science ®Google Scholar
• Hardy WD, Feinberg J, Finkelstein DM, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med. 1992;327(26):1842–1848.
   PubMed Web of Science ®Google Scholar
• Mallolas J, Zamora L, Gatell JM, et al. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. Aids. 1993;7(1):59–64.
   PubMed Web of Science ®Google Scholar
• Sattler FR, Cowan R, Nielsen DM, et al. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann Intern Med. 1988;109(4):280–287.
   PubMed Web of Science ®Google Scholar
• Song Y, Ren Y Wang X, et al. Recent advances in the diagnosis of Pneumocystis pneumonia. Med Mycol J. 2016;57E:E111–E116.
   Google Scholar
• Daly KR, Fichtenbaum CJ, Tanaka R, et al. Serologic responses to eiptoes of the major surface glycoprotein of Pneumocystis jirovecii differ in human immunodeficiency virus infected and uninfected persons. J Infect Dis. 2002;186:644–651.
   PubMed Web of Science ®Google Scholar
• Daly KR, Huang L, Morris A, et al. Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis. 2006;12:1231–1237.
   PubMed Web of Science ®Google Scholar
• Hauser PM, Nahimana A, Taffe P, et al. Inter-human transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis. 2010;51(4):e28–33.
   PubMed Web of Science ®Google Scholar